FAMILIAL ADENOMATOUS POLYPOSIS – A CASE REPORT

Thị Thảo Đinh, Quang Trung Pham, Phương Giang Đào, Thuỳ Dương Bạch , Doãn Kỳ Thái, Tất Trung Ngô

Main Article Content

Abstract

Familial adenomatous polyposis (FAP) is a rare genetic disorder characterized by the presence of hundreds to thousands of polyps in the colon. Testing for APC gene mutations plays a crucial role in screening and early detection of this disease. Here, we report a case of a 36-year-old individual with asymptomatic FAP identified through endoscopic imaging and genetic testing

Article Details

References

1. Aihara, H., N. Kumar, and C.C. Thompson, Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update. Eur J Gastroenterol Hepatol, 2014. 26(3): p. 255-62.
2. Leoz, M.L., et al., The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl Clin Genet, 2015. 8: p. 95-107.
3. Hutter, P., et al., Molecular and clinical characteristics in 32 families affected with familial adenomatous polyposis. Hum Mutat, 2001. 18(6): p. 550.
4. Miyoshi, Y., et al., Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci U S A, 1992. 89(10): p. 4452-6.
5. Miyoshi, Y., et al., Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet, 1992. 1(4): p. 229-33.
6. Half, E., D. Bercovich, and P. Rozen, Familial adenomatous polyposis. Orphanet J Rare Dis, 2009. 4: p. 22.
7. Nielsen, M., et al., Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet, 2007. 71(5): p. 427-33.
8. Zehir, A., et al., Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. 2017. 23(6): p. 703-713.
9. Iwama, T., et al., Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence. Fam Cancer, 2009. 8(1): p. 51-4.